NCT02723994 2026-03-11A Phase 2 Study of Ruxolitinib With Chemotherapy in Children With Acute Lymphoblastic LeukemiaIncyte CorporationPhase 2 Completed171 enrolled
NCT05700448 2026-02-05Study of Sugemalimab (or Placebo) Plus PGemOx Regimen in Participants With Extranodal NK/T-Cell LymphomaCStone PharmaceuticalsPhase 3 Not yet recruiting150 enrolled